UKHCDO
  • Home
    • Haemophilia Centre List
    • Haemtrack
    • Vacancies
  • News
  • UKHCDO
    • Annual General Meetings
    • Annual Reports
    • Annual Reports – Scotland and Wales
    • Peer Review
  • Working Parties
    • Advisory Committee
    • Data Management Working Party
    • Data Analysis Group
    • Genomics Working Party
    • Inhibitor Working Party
    • Laboratory Working Party
    • Co-Morbidities Working Party
    • Musculoskeletal Working Party
    • Paediatric Working Party
    • Peer Review Working Party
    • Von Willebrand Disease Working Party
    • Girls and Women with Bleeding Disorders Working Party
  • NHD
  • Associations
    • Haemophilia Chartered Physiotherapists Association (HCPA)
    • Haemophilia Psychology Association (HPA)
  • Guidelines
  • Patient Info
  • Links
  • Contact Us
  • Menu Menu
Greg Shone

Annual General Meeting 2025

June 27, 2025/in Annual General Meeting, News/by Greg Shone

UKHCDO Educational & Annual General Scientific Meeting 2025

Thursday 6th & Friday 7th November
Radisson Blu Hotel, London Bloomsbury
9 – 13 Bloomsbury Street
London
WC1B 3QD
United Kingdom

The following organisations have provided sponsorship to UKHCDO to cover the cost of stand space and industry delegate passes only. No sponsor has had influence over the meeting agenda or arrangements:

Pfizer Ltd., Octapharma Ltd., CSL Behring UK Ltd., Novo Nordisk Ltd., Roche Products Ltd., Swedish Orphan Biovitrum Ltd., Takeda UK Ltd., LFB Biopharmaceuticals Ltd., Bio Products Laboratory Ltd., Hemab Therapeutics.

Educational Day 6th November – Materials

Lize van Vulpen – Ankle Distraction Data

Anne Riddell – Laboratory issues in the monitoring of efanesoctacog alpha (Part 1)

Anna Williams – Laboratory issues in the monitoring of efanesoctacog alpha (Part 2)

https://www.ukhcdo.org/wp-content/uploads/2018/08/353x500_NHD_Logo.png 107 500 Greg Shone https://ukhcdo.org/wp-content/uploads/2018/08/UKHCDO_LOGO_340x156_white1-300x138.png Greg Shone2025-06-27 12:59:242025-12-15 10:59:27Annual General Meeting 2025
Alex Godsall

UKHCDO and the Infected Blood Compensation Authority

June 4, 2025/in News/by Alex Godsall

UKHCDO has been asked to share confidential patient data with the Infected Blood Compensation Authority (IBCA). Data sharing from the UKHCDO enables IBCA to have access to the data held by the National Haemophilia Database on treatment for bleeding disorders, which may be directly or indirectly relevant to the eligibility criteria for claiming compensation as recommended by the Infected Blood Inquiry. This data will hopefully supplement data from other sources to support applications for compensation. UKHCDO will continue to share this important data with IBCA to support its processing of claims from infected and affected individuals until this process is complete.

The legal basis for sharing and processing personal data between both organisations is being undertaken further to statutory obligations and remit as set out by the Victims and Prisoners Act 2024 and relevant GDPR articles for each organisation. For more information on UKHCDO’s lawful basis, please see our data privacy policy.

https://www.ukhcdo.org/wp-content/uploads/2025/06/668A7F07-B5BA-480B-8340568B88864FDD_carouselimage.jpg 628 1506 Alex Godsall https://ukhcdo.org/wp-content/uploads/2018/08/UKHCDO_LOGO_340x156_white1-300x138.png Alex Godsall2025-06-04 10:28:222025-06-04 10:33:31UKHCDO and the Infected Blood Compensation Authority

News

  • ISTH Congress 11 – 15 July 2026
  • EHA Congress 11-14 June 2026
  • Annual General Meeting 2026
  • Certification Success again!
  • Certification Success

Categories

  • Annual General Meeting (8)
  • Blood Enquiry (1)
  • Clinical Research (2)
  • Meetings (6)
  • News (39)
  • Home
  • About UKHCDO

 

  • Guidelines
  • Working Parties
  • National Haemophilia Database
  • Haemtrack
  • Contact Details
  • Useful Links
Scroll to top Scroll to top Scroll to top